Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.4341
-0.0109 (-2.45%)
At close: Mar 11, 2026, 4:00 PM EDT
0.4300
-0.0041 (-0.94%)
After-hours: Mar 11, 2026, 4:37 PM EDT

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $-1.21M in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to $205.70K. In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M.

Revenue (ttm)
$205.70K
Revenue Growth
n/a
P/S Ratio
179.70
Revenue / Employee
$12,100
Employees
17
Market Cap
36.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20251.41M--
Sep 30, 2024---
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020---
Sep 30, 20198.15M5.06M163.84%
Sep 30, 20183.09M-723.96K-18.99%
Sep 30, 20173.81M831.94K27.92%
Sep 30, 20162.98M-2.24M-42.91%
Sep 30, 20155.22M-3.83M-42.33%
Sep 30, 20149.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Celularity40.58M
Veru Inc.16.89M
Palatin Technologies8.96M
Pluri1.34M
Werewolf Therapeutics1.14M
ABVC BioPharma797.92K
Actinium Pharmaceuticals90.00K
Revenue Rankings

OTLK News

More News